TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps a Buy rating on the shares. The firm expects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback